Why the study?
Hypertension prevalence is increasing in India with widespread lack of awareness, poor healthcare, and non-compliance affecting management and outcomes.
Observational
Significant price variations exist among different brands of the same antihypertensive medications in India, highlighting the need for rational prescribing to reduce patient economic burden.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Selva et al. (2019) conducted an observational in Hypertension. Oral antihypertensive drugs was evaluated on Percentage variation in cost.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: